A recent study has identified THRAP3 as a key factor in promoting resistance to ferroptosis, a regulated form of cell death that has been the focus of emerging cancer therapies. Researchers have found that acute myelocytic leukemia (AML) cells utiliz…
Study Identifies THRAP3 as a Key Factor in AML Cell Resistance to Ferroptosis Through SLU7 Splicing
